Your browser doesn't support javascript.
loading
Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.
Bastos, Marcele F; Kayano, Ana Carolina A V; Silva-Filho, João Luiz; Dos-Santos, João Conrado K; Judice, Carla; Blanco, Yara C; Shryock, Nathaniel; Sercundes, Michelle K; Ortolan, Luana S; Francelin, Carolina; Leite, Juliana A; Oliveira, Rafaella; Elias, Rosa M; Câmara, Niels O S; Lopes, Stefanie C P; Albrecht, Letusa; Farias, Alessandro S; Vicente, Cristina P; Werneck, Claudio C; Giorgio, Selma; Verinaud, Liana; Epiphanio, Sabrina; Marinho, Claudio R F; Lalwani, Pritesh; Amino, Rogerio; Aliberti, Julio; Costa, Fabio T M.
Afiliación
  • Bastos MF; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Kayano ACAV; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Silva-Filho JL; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Dos-Santos JCK; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Judice C; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Blanco YC; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Shryock N; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Sercundes MK; Department of Clinical and Toxicological Analyses, University of São Paulo, São Paulo, Brazil.
  • Ortolan LS; Department of Clinical and Toxicological Analyses, University of São Paulo, São Paulo, Brazil.
  • Francelin C; Department of Functional and Structural Biology, University of Campinas, Campinas, Brazil.
  • Leite JA; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Oliveira R; Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil.
  • Elias RM; Department of Immunology, University of São Paulo, São Paulo, Brazil.
  • Câmara NOS; Department of Immunology, University of São Paulo, São Paulo, Brazil.
  • Lopes SCP; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Albrecht L; Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil.
  • Farias AS; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Vicente CP; Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Brazil.
  • Werneck CC; Department of Genetics, Evolution, Microbiology, and Immunology, Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, University of Campinas, Campinas, Brazil.
  • Giorgio S; Department of Clinical and Toxicological Analyses, University of São Paulo, São Paulo, Brazil.
  • Verinaud L; Department of Biochemistry and Tissue Biology, University of Campinas, Campinas, Brazil.
  • Epiphanio S; Department of Animal Biology, University of Campinas, Campinas, Brazil.
  • Marinho CRF; Department of Functional and Structural Biology, University of Campinas, Campinas, Brazil.
  • Lalwani P; Department of Clinical and Toxicological Analyses, University of São Paulo, São Paulo, Brazil.
  • Amino R; Department of Parasitology, University of São Paulo, São Paulo, Brazil.
  • Aliberti J; Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil.
  • Costa FTM; Unit of Malaria Infection and Immunity, Institut Pasteur, Paris, France.
FASEB J ; 32(8): 4470-4481, 2018 08.
Article en En | MEDLINE | ID: mdl-29558201
ABSTRACT
Cerebral malaria (CM) is a multifactorial syndrome involving an exacerbated proinflammatory status, endothelial cell activation, coagulopathy, hypoxia, and accumulation of leukocytes and parasites in the brain microvasculature. Despite significant improvements in malaria control, 15% of mortality is still observed in CM cases, and 25% of survivors develop neurologic sequelae for life-even after appropriate antimalarial therapy. A treatment that ameliorates CM clinical signs, resulting in complete healing, is urgently needed. Previously, we showed a hyperbaric oxygen (HBO)-protective effect against experimental CM. Here, we provide molecular evidence that HBO targets brain endothelial cells by decreasing their activation and inhibits parasite and leukocyte accumulation, thus improving cerebral microcirculatory blood flow. HBO treatment increased the expression of aryl hydrocarbon receptor over hypoxia-inducible factor 1-α (HIF-1α), an oxygen-sensitive cytosolic receptor, along with decreased indoleamine 2,3-dioxygenase 1 expression and kynurenine levels. Moreover, ablation of HIF-1α expression in endothelial cells in mice conferred protection against CM and improved survival. We propose that HBO should be pursued as an adjunctive therapy in CM patients to prolong survival and diminish deleterious proinflammatory reaction. Furthermore, our data support the use of HBO in therapeutic strategies to improve outcomes of non-CM disorders affecting the brain.-Bastos, M. F., Kayano, A. C. A. V., Silva-Filho, J. L., Dos-Santos, J. C. K., Judice, C., Blanco, Y. C., Shryock, N., Sercundes, M. K., Ortolan, L. S., Francelin, C., Leite, J. A., Oliveira, R., Elias, R. M., Câmara, N. O. S., Lopes, S. C. P., Albrecht, L., Farias, A. S., Vicente, C. P., Werneck, C. C., Giorgio, S., Verinaud, L., Epiphanio, S., Marinho, C. R. F., Lalwani, P., Amino, R., Aliberti, J., Costa, F. T. M. Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Oxigenoterapia_hiperbrica Asunto principal: Oxígeno / Encéfalo / Malaria Cerebral / Quinurenina / Hipoxia Tipo de estudio: Risk_factors_studies Idioma: En Revista: FASEB J Año: 2018 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Oxigenoterapia_hiperbrica Asunto principal: Oxígeno / Encéfalo / Malaria Cerebral / Quinurenina / Hipoxia Tipo de estudio: Risk_factors_studies Idioma: En Revista: FASEB J Año: 2018 Tipo del documento: Article País de afiliación: Brasil